Walz D T, Dimartino M J, Griswold D E
J Rheumatol Suppl. 1982 Jul-Aug;8:32-6.
Auranofin (AF) and gold sodium thiomalate (GSTM) were evaluated in antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent antibody responses. AF decreased the ability of immune sera to participate in ADCC, whereas GSTM did not. Immune serum from AF-treated rats also exhibited a decreased antibody-dependent complement lysis (ADCL) reactivity. In contrast, immune sera from GSTM-treated rats enhanced ADCL. AF also suppressed '7S' hemagglutinin antibody response to sheep red blood cells in adjuvant arthritic rats, whereas neither GSTM nor gold sodium thioglucose significantly suppressed hemagglutinin antibody titers at doses which produced antiinflammatory activity.